June 24 to 26, 2025, the 23rd CPHI China was held at the Shanghai New International Expo Centre. CPHI China 2025 was held on a grand scale, featuring over 3,500 global exhibitors and attracting more than 100,000 professional visitors.

Hydrogen chloride gas (HCl gas) is widely used in the synthesis of various pharmaceutical intermediates, as well as in other pharmaceutical production steps. HCl gas is a key raw material in the pharmaceutical industry. In addition, upon recent years, it has increasingly been used by pharmaceutical intermediate manufacturers as a replacement for hydrochloric acid, to solve the  high cost issue for used hydrochloric acid treatment.

As a leading supplier with over 20 years of experience in the production and supply of hydrogen chloride gas in China, HYTF made a strong debut at the exhibition, showcasing HCl gas products to the pharmaceutical industry.

In the 1990s, HYTF established the first set hydrogen chloride (HCl) production unit in China. Recognized in the early 2000s as “the enterprise that filled the domestic gap in HCl gas production”, HYTF has committed to independently developing proprietary technologies for production, filling, and passivation, until now, HYTF holds 17 patented technologies.

HYTF also independently developed an production system for electronic-grade hydrogen chloride, and has been granted a national invention patent. With high purity HCl gas production unit, 5N and 5N5 HCl gas in compliance with SEMI international standards.

Along with HYTF’s 2nd production plant turned to use, we has significantly enhanced our overall supply capacity, strengthened product competitiveness, expanded R&D platform, and improved technical service capabilities. These improvements support business expansion into new industries and help increase market share in existing segments.

In the pharmaceutical sector, HYTF has always prioritized product quality and supply stability. We actively responds to customer needs and has established partnerships with over 100 clients in domestic and overseas, including long-term stable cooperation with several industry-leading enterprises.

During CPHI China 2025, HYTF attracted more than 200 new and existing pharmaceutical raw material partners worldwide, which highlighting our strong influence in the industry and appeal as a reliable collaborative partner.

Looking to the future，HYTF shall continue to deepen our expertise in the hydrogen chloride (HCl) gas manufacturing and supplying, steadily optimizing production processes, services and product quality. We shall committed to ensuring a stable supply of HCl gas across multiple purity levels—including chemical-grade and electronic-grade—as well as high-purity electronic-grade chlorine gas, serving industries including electronics, semiconductors, and various chemical industries.

With consistently improved product quality and technical support, we will continue to provide superior product solutions for customers in the global pharmaceutical raw materials industry.